» Sun Pharma Advanced Research company (SPARC) News

Sun Pharma Advanced Research company (SPARC)

Sun Pharma Advanced Research Q4 net loss widens to Rs 81.99 crore

Sun Pharma Advanced Research Q4 net loss widens to Rs 81.99 crore

Mon, May 22, 2023

The company had posted a net loss of Rs 71.05 crore in the same period previous fiscal, Sun Pharma Advanced Research Company said in a regulatory filing.

More >

SPARC signs licensing pact with Visiox Pharma for ophthalmic products

SPARC signs licensing pact with Visiox Pharma for ophthalmic products

Wed, Dec 08, 2021

The company has entered into an agreement with Visiox Pharma LLC (Visiox) to grant exclusive worldwide rights (except for India and Greater China) for the development and commercialisation of PDP-716 and SDN-037, SPARC said in a statement.

More >

SPARC's net loss widens to Rs 36 crore

SPARC's net loss widens to Rs 36 crore

Fri, Jul 29, 2016

SPARC reported widening of standalone net loss to Rs 36.41 crore for the first quarter ended June 30. The company had posted a net loss of Rs 1.65 crore for the corresponding period of the previous fiscal. 

More >

TRENDING NOW

SBI 444-day FD vs PNB 400-day FD: Here's what general and senior citizens will get in maturity on Rs 3.5 lakh and 7 lakh investments in special FDs?

SBI 444-day FD vs PNB 400-day FD: Here's what general and senior citizens will get in maturity on Rs 3.5 lakh and 7 lakh investments in special FDs?

Small SIP, Big Impact: Rs 1,111 monthly SIP for 40 years, Rs 11,111 for 20 years or Rs 22,222 for 10 years, which do you think works best?

Small SIP, Big Impact: Rs 1,111 monthly SIP for 40 years, Rs 11,111 for 20 years or Rs 22,222 for 10 years, which do you think works best?

SCSS vs FD: Which guaranteed return scheme will give you more quarterly income on Rs 20,00,000 investment?

SCSS vs FD: Which guaranteed return scheme will give you more quarterly income on Rs 20,00,000 investment?

Power of Compounding: How soon will monthly SIP of Rs 11,000 reach Rs 8 crore corpus target?

Power of Compounding: How soon will monthly SIP of Rs 11,000 reach Rs 8 crore corpus target?

PPF Calculations: How to get Rs 72,000 a month tax-free income from Public Provident Fund?

PPF Calculations: How to get Rs 72,000 a month tax-free income from Public Provident Fund?

Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations

Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations

Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets

Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets

Power of Compounding: How long it will take to build Rs 5 crore corpus with Rs 5,000, Rs 10,000 and Rs 15,000 monthly investments?

Power of Compounding: How long it will take to build Rs 5 crore corpus with Rs 5,000, Rs 10,000 and Rs 15,000 monthly investments?

Sun, Dr Reddy's, Glenmark strengthen their US play

Sun, Dr Reddy's, Glenmark strengthen their US play

Mon, Jul 18, 2016

Domestic pharma players are in stiff competition in US market. Sun Pharma with its taking over of SPARC's ELEPSIA XR, while Dr. Reddy launching Omeprazole and Sodium bicarbonate capsules and that of Glenmark waiting for 62 ANDA's approval, plans to strenghthen their position in the US. 

More >

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x